News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Articles by Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

ByRobert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD,Brenda Motheral, PhD,Doug Mager, BS

April 1st 2004

Latest Updated Articles

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)
April 1st 2004

Trending on AJMC

Four Major Idiopathic Pulmonary Fibrosis Advances From 2026

Machine Learning Has High Accuracy, Little Prospective Validation in MPNs

BPC-157 'Wolverine Peptide' Use Rose 33-Fold Despite Scant Evidence

The Next Decade of Cancer Care Is Coming Home: Who Will Be in the Driver’s Seat?

HHS Draft Policy Eases Enforcement on 6 Compounded Peptides